EOG Resources Inc vs Medpace Holdings Inc — how do they compare? EOG Resources Inc trades at $143.02 (market cap $75.22B), while Medpace Holdings Inc trades at $601.1 (market cap $16.90B). The key difference: EOG Resources Inc is far larger — about 4.5× Medpace Holdings Inc's market cap, and EOG Resources Inc pays a 2.85% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| EOG | MEDP | |
|---|---|---|
Market Cap | $75.22B | $16.90B |
Sector | Energy | Technology |
52-Week High | $149.89 | $620.59 |
52-Week Low | $101.78 | $393.42 |
Enterprise Value | $78.56B | $16.52B |
Dividend Yield | 2.85% | — |
Signals from Pluang's Aura AI — not financial advice
EOG Resources trades at $142.4, up 0.13% today, with a bullish technical signal and strong fundamentals. The stock shows robust profitability with a 25.81% net income margin and a low P/E of 11.16. Recent Q2 2026 earnings of $5.07 per share beat estimates, driven by higher oil prices and production. Analyst consensus is a Buy with a $157.88 price target, and institutional interest remains positive.
The outlook for EOG is favorable, supported by consistent earnings beats, shareholder returns via dividends, and a disciplined growth strategy. Key risks include oil price volatility and capital expenditure outflows. The stock presents a value opportunity with upside potential, but investors should monitor energy market trends and execution on international projects.
MEDP trades at $600.00, down 0.4% on the day, with a bullish technical signal driven by moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $4.25, and raised full-year guidance. Revenue growth is robust, with 2026 projected at $2.8 billion, though valuation multiples like a P/E of 35.58 and P/B of 38.95 are elevated. Net cash flow is expected to turn positive in 2026, and institutional activity is mixed, with some funds increasing stakes while others trim positions.
Outlook is positive due to earnings momentum and record bookings, but risks include high valuation sensitivity and a shareholder lawsuit investigation. Analyst consensus is a $599.57 price target with a 'Hold' bias, suggesting limited near-term upside from current levels amid growth-priced expectations.
Trailing returns across standard periods
Latest headlines on both assets
EOG Resources is an oil and gas producer with acreage in several U.S. shale plays, including the Permian Basin, the Eagle Ford, and the Bakken. At the end of 2021, it reported net proved reserves of 3.7 billion barrels of oil equivalent. Net production averaged 829 thousand barrels of oil equivalent per day in 2021 at a ratio of 72% oil and natural gas liquids and 28% natural gas.
Read more on EOG →Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →